The Scientific Team at ProQR Therapeutics is responsible for the discovery, development, and optimization of innovative RNA therapies aimed at treating inherited retinal diseases. This team of experts conducts cutting-edge research, designs preclinical studies, and oversees the scientific strategy and communication to advance potential therapies from concept to clinical application.
View all